+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oligonucleotide Synthesis Market by Product, Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User - Global Forecast to 2024

  • ID: 4769493
  • Report
  • Region: Global
  • 226 pages
  • Markets and Markets
1 of 6
The Global Oligonucleotide Synthesis Market is Projected to Reach USD 8.2 Billion by 2024 from USD 4.3 Billion in 2019

FEATURED COMPANIES

  • Adtbio
  • Agilent Technologies
  • Bio-Synthesis Inc.
  • Eurofins Genomics
  • Eurogentec
  • GE Healthcare
  • MORE

Oligonucleotide Synthesis Market by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) - Global Forecast to 2024

“Increasing R&D expenditure by pharmaceutical and biotechnology companies and the rising demand for synthesized oligos in molecular diagnostics & therapeutics are expected to drive the overall growth of the oligonucleotide synthesis market”

The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. The increasing applications of oligos in nucleic acid array-based technologies, library preparation, NGS, genomics, nucleic acid-based detection, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology are also driving the growth of this market.

“Hospitals accounted for the largest share of the oligonucleotide synthesis market, by end user, in 2018”

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals. Hospitals held the largest share of the market in 2018 due to the significant number of inpatient and outpatient visits in hospitals and the requirement of oligonucleotide drugs to cater to the demand of the patient pool suffering from diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and hepatic veno-occlusive disease.

“Synthesized oligos dominated the oligonucleotide synthesis market, by product, in 2018"

Based on product, the market is segmented into synthesized oligos, reagents, and equipment. The synthesized oligos segment held the largest share of the market in 2018 and is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the increasing applications of synthesized oligos in therapeutics, research, and diagnostics.

“North America to dominate the market during the forecast period”

Geographically, the oligonucleotide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest regional market for oligonucleotide synthesis. The North American market is also estimated to grow at the highest CAGR during the forecast period owing to the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the North American region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
  • By Designation - C-level: 45%, D-level: 35%, and Others: 20%
  • By Region - North America: 45%, Europe: 25%, Asia Pacific: 18%, Latin America: 7%, and Middle East and Africa: 3%

List of Companies Profiled in the Report include

  • Agilent Technologies, Inc. (US)
  • ATDBio Ltd. (UK)
  • Bio-Synthesis, Inc. (US)
  • BioAutomation Corporation (US)
  • LGC Biosearch Technologies (US)
  • Eurofins Genomics (Germany)
  • Eurogentec (Belgium)
  • GeneDesign, Inc. (Japan)
  • GE Healthcare (US)
  • GenScript, Inc. (US)
  • Integrated DNA Technologies (IDT, US)
  • Nitto Denko Avecia, Inc. (US)
  • Sarepta Therapeutics (US)
  • Thermo Fisher Scientific, Inc. (US)
  • TriLink BioTechnologies (US)
  • Sigma-Aldrich Corporation (US) (a part of Merck KGAA)

Research Coverage:
This report provides a detailed picture of the global oligonucleotide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such as product & type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall oligonucleotide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Adtbio
  • Agilent Technologies
  • Bio-Synthesis Inc.
  • Eurofins Genomics
  • Eurogentec
  • GE Healthcare
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Market Size Estimation: Bottom-Up Approach
2.4.2 Market Size Estimation: Top-Down Approach
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in the Oligonucleotide Synthesis Market
4.2 Synthesized Oligos Market, By Product
4.3 Synthesized Oligos Market, By Type
4.4 Asia Pacific: Oligonucleotide Synthesis Market, By Research Application and Country (2019)
4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
4.6 Oligonucleotide Synthesis Market, By End User
4.7 Geographic Snapshot: Oligonucleotide Synthesis Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications
5.2.1.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
5.2.1.3 Rise in Venture Capital Investments
5.2.2 Market Restraints
5.2.2.1 Price Erosion of Synthesized Oligos
5.2.2.2 Lack of A Unified Set of Regulations for Therapeutic Oligos
5.2.3 Market Opportunities
5.2.3.1 Emerging Asian Markets
5.2.4 Market Challenges
5.2.4.1 Large-Scale Synthesis of Oligos
5.2.4.2 Delivery of Oligonucleotide Drugs to Specific Targets

6 Oligonucleotide Synthesis Market, By Product
6.1 Introduction
6.2 Synthesized Oligos
6.2.1 Synthesized Oligos Market, By Product
6.2.1.1 Oligonucleotide-Based Drugs
6.2.1.1.1 Oligonucleotide-Based Drugs Dominate the Synthesized Oligos Market, By Product
6.2.1.2 Primers
6.2.1.2.1 Growing Research Activity Drives the Market for Primers
6.2.1.3 Probes
6.2.1.3.1 Probes are Designed to Detect Various Infectious Agents
6.2.1.4 Intermediate-Scale Synthesized Oligos
6.2.1.4.1 The Increasing Demand for Synthesized Oligos and Innovations in Manufacturing Techniques Drives the Market.
6.2.1.5 Large-Scale Synthesized Oligos
6.2.1.5.1 Increasing Demand for Large Quantities of Modified and Unmodified Oligos to Drive the Market
6.2.1.6 Linkers & Adaptors
6.2.1.6.1 Linkers are Used to Add Restriction Sites in DNA
6.2.2 Synthesized Oligos Market, By Type
6.2.2.1 Predesigned Oligos
6.2.2.1.1 Predesigned Oligos Dominate the Oligonucleotide Synthesis Market, By Type
6.2.2.2 Custom Oligos
6.2.2.2.1 Increasing Number of Clinical and Pre-Clinical Research to Drive the Market for Custom Oligos
6.3 Reagents
6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application
7.1 Introduction
7.2 Therapeutic Applications
7.2.1 DNA & Antisense Oligonucleotide-Based therapies
7.2.1.1 DNA & Antisense Oligos Form the Largest Segment in the Therapeutic Applications Market
7.2.2 RNAi Oligonucleotide-Based therapies
7.2.2.1 Significant Initiatives By Pharmaceutical and Biotechnology Companies to Drive the Market for RNAi Oligonucleotide-Based therapies
7.2.3 Cpg Oligonucleotide-Based therapies
7.2.3.1 This Market Segment is in the Initial Stage, and Significant Growth Might Be Observed During the Forecast Period
7.3 Diagnostic Applications
7.4 Research Applications
7.4.1 PCR
7.4.1.1 Increasing Use of PCR in Research to Drive Market Growth
7.4.2 QPCR
7.4.2.1 Its Cost-Effectiveness, Concurrent Monitoring of Expression Levels of Multiple Genetic Messages in Real Time, and High Sensitivity Make QPCR A Vital Tool for Quantification of Nucleic Acids
7.4.3 Sequencing
7.4.3.1 Advancements in Sequencing Technologies and Low Cost to Drive the Market for Sequencing Applications
7.4.4 Gene Synthesis
7.4.4.1 Increasing Applications of Gene Synthesis and Low Cost to Drive the Market for This Application Segment
7.4.5 Other Research Applications

8 Oligonucleotide Synthesis Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals are the Largest End Users of Oligos Due to the Significant Number of Inpatient and Outpatient Visits
8.3 Academic Research Institutes
8.3.1 Academic Researchers Primarily Use Oligos for Genetic Engineering, PCR Activities, and High-Throughput Sequencing - A Major Factor Driving Market Growth
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Growing Applications of Oligos in Drug Discovery & Therapeutics to Drive the Demand for Oligonucleotide Synthesis Among these End Users
8.5 Diagnostic Laboratories
8.5.1 Diagnostic Laboratories Register High Growth in the Oligonucleotide Synthesis Market Due to the Increasing Significance of Oligos in Molecular Diagnostics

9 Oligonucleotide Synthesis Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Government Initiatives and Strategic Developments By Market Players to Drive Market Growth in the Country
9.2.2 Canada
9.2.2.1 Growing Initiatives and Funding in Synthetic Biology and Genomics to Drive the Market in the Country
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic Research Institutes to Support Market Growth
9.3.2 France
9.3.2.1 Government Initiatives to Boost R&D Activities in the Country
9.3.3 UK
9.3.3.1 Growth in the Life Science Industry to Drive the Market for Oligonucleotides Synthesis in the UK
9.3.4 Italy
9.3.4.1 Increasing Research Activities to Drive the Market for Oligonucleotides Synthesis in Italy
9.3.5 Spain
9.3.5.1 Government Initiatives to Drive the Market for Oligonucleotide Synthesis
9.3.6 RoE
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Government Initiatives to Strengthen the Biotechnology Industry in China
9.4.2 Japan
9.4.2.1 Increasing Awareness Through Conferences and Workshops to Drive the Market in the Country
9.4.3 India
9.4.3.1 Government Initiatives to Promote Synthetic Biology to Drive the Market in the Country
9.4.4 RoAPAC
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Development in Genomics to Aid Market Growth in Brazil
9.5.2 Mexico
9.5.2.1 Increasing Awareness About Advancements in Oligonucleotides to Drive the Market
9.5.3 RoLATAM
9.6 Middle East & Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, Contracts, and Collaborations
10.3.2 Product Launches, Upgrades, and Approvals
10.3.3 Expansions
10.3.4 Acquisitions
10.4 Competitive Leadership Mapping (2017)
10.4.1 Vanguards
10.4.2 Innovators
10.4.3 Dynamic Players
10.4.4 Emerging Players
10.5 Competitive Leadership Mapping for Start-Ups (2018)
10.5.1 Progressive Companies
10.5.2 Starting Blocks
10.5.3 Responsive Companies
10.5.4 Dynamic Companies
10.6 MnM Dive-Vendor Comparison Matrix for Start-Ups: Oligonucleotide Synthesis Market

11 Company Profiles
(Business Overview, Products/Services Offered, Recent Developments, and Author's View)*
11.1 Agilent Technologies
11.2 Adtbio
11.3 Bioautomation (Acquired By LGC
11.4 Bio-Synthesis Inc.
11.5 Eurofins Genomics
11.6 Eurogentec
11.7 GE Healthcare
11.8 Genscript
11.9 Genedesign (Part of Ajinomoto
11.10 Integrated DNA Technologies (Acquired By Danaher Corporation)
11.11 LGC Biosearch Technologies
11.12 Merck KGaA
11.13 Nitto Denko Avecia
11.14 Thermo Fisher Scientific
11.15 TriLink Biotechnologies (Part of Maravai Lifesciences)
* Business Overview, Products/Services Offered, Recent Developments, and Author's View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights From Industry Experts
12.2 Discussion Guide

List of Tables
Table 1 Fda-Approved Oligonucleotide-Based Therapies
Table 2 Oligonucleotide Synthesis: Market, By Product, 2017–2024 (USD Million)
Table 3 Synthesized Oligos Market, By Region, 2017–2024 (USD Million)
Table 4 Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 5 Late-Stage Oligonucleotide-Based therapies
Table 6 Oligonucleotide-Based Drugs Market, By Region, 2017–2024 (USD Million)
Table 7 Primers Market, By Region, 2017–2024 (USD Million)
Table 8 Probes Market, By Region, 2017–2024 (USD Million)
Table 9 Oligonucleotide Synthesis: Market for Intermediate-Scale Synthesized Oligos, By Region, 2017–2024 (USD Million)
Table 10 Large-Scale Synthesized Oligos Market, By Region, 2017–2024 (USD Million)
Table 11 Linkers & Adaptors Market, By Region, 2017–2024 (USD Million)
Table 12 Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 13 Predesigned Oligos Market, By Region, 2017–2024 (USD Million)
Table 14 Custom Oligos Market, By Region, 2017–2024 (USD Million)
Table 15 Oligonucleotide Synthesis Reagents Market, By Region, 2017–2024 (USD Million)
Table 16 Oligonucleotide Synthesis Equipment Market, By Region, 2017–2024 (USD Million)
Table 17 Market, By Application, 2017–2024 (USD Million)
Table 18 Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 19 Market for Therapeutic Applications, By Region, 2017–2024 (USD Million)
Table 20 Antisense Oligonucleotides in Clinical Trials
Table 21 Market for DNA & Antisense Oligonucleotide-Based therapies, By Region, 2017–2024 (USD Million)
Table 22 Market for RNAi Oligonucleotide-Based therapies, By Region, 2017–2024 (USD Million)
Table 23 Market for Cpg Oligonucleotide-Based therapies, By Region, 2017–2024 (USD Million)
Table 24 Market for Diagnostic Applications, By Region, 2017–2024 (USD Million)
Table 25 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 26 Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 27 Market for PCR Applications, By Region, 2017–2024 (USD Million)
Table 28 Market for QPCR Applications, By Region, 2017–2024 (USD Million)
Table 29 Market for Sequencing Applications, By Region, 2017–2024 (USD Million)
Table 30 Market for Gene Synthesis Applications, By Region, 2017–2024 (USD Million)
Table 31 Market for Other Research Applications, By Region, 2017–2024 (USD Million)
Table 32 Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 34 Market for Academic Research Institutes, By Region, 2017–2024 (USD Million)
Table 35 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 36 Market for Diagnostic Laboratories, By Region, 2017–2024 (USD Million)
Table 37 Market, By Region, 2017–2024 (USD Million)
Table 38 North America: Market, By Country, 2017–2024 (USD Million)
Table 39 North America: Market, By Product, 2017–2024 (USD Million)
Table 40 North America: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 41 North America: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 42 North America: Market, By Application, 2017–2024 (USD Million)
Table 43 North America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 44 North America: Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 US: Oligonucleotide Synthesis Market, By Product, 2017–2024 (USD Million)
Table 47 US: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 48 US: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Application, 2017–2024 (USD Million)
Table 50 US: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 51 US: Market, By End User, 2017–2024 (USD Million)
Table 52 Canada: Market, By Product, 2017–2024 (USD Million)
Table 53 Canada: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 54 Canada: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 55 Canada: Market, By Application, 2017–2024 (USD Million)
Table 56 Canada: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 57 Canada: Market, By End User, 2017–2024 (USD Million)
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Product, 2017–2024 (USD Million)
Table 60 Europe: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 61 Europe: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 62 Europe: Market, By Application, 2017–2024 (USD Million)
Table 63 Europe: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 64 Europe: Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 65 Europe: Market, By End User, 2017–2024 (USD Million)
Table 66 Germany: Market, By Product, 2017–2024 (USD Million)
Table 67 Germany: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 68 Germany: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 69 Germany: Market, By Application, 2017–2024 (USD Million)
Table 70 Germany: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 71 Germany: Market, By End User, 2017–2024 (USD Million)
Table 72 France: Market, By Product, 2017–2024 (USD Million)
Table 73 France: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 74 France: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 75 France: Market, By Application, 2017–2024 (USD Million)
Table 76 France: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 77 France: Market, By End User, 2017–2024 (USD Million)
Table 78 UK: Market, By Product, 2017–2024 (USD Million)
Table 79 UK: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 80 UK: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 81 UK: Market, By Application, 2017–2024 (USD Million)
Table 82 UK: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 83 UK: Market, By End User, 2017–2024 (USD Million)
Table 84 Italy: Market, By Product, 2017–2024 (USD Million)
Table 85 Italy: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 86 Italy: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 87 Italy: Market, By Application, 2017–2024 (USD Million)
Table 88 Italy: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 89 Italy: Market, By End User, 2017–2024 (USD Million)
Table 90 Spain: Market, By Product, 2017–2024 (USD Million)
Table 91 Spain: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 92 Spain: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 93 Spain: Market, By Application, 2017–2024 (USD Million)
Table 94 Spain: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 95 Spain: Market, By End User, 2017–2024 (USD Million)
Table 96 RoE: Market, By Product, 2017–2024 (USD Million)
Table 97 RoE: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 98 RoE: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 99 RoE: Market, By Application, 2017–2024 (USD Million)
Table 100 RoE: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 101 RoE: Market, By End User, 2017–2024 (USD Million)
Table 102 APAC: Market, By Country, 2017–2024 (USD Million)
Table 103 APAC: Market, By Product, 2017–2024 (USD Million)
Table 104 APAC: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 105 APAC: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 106 APAC: Market, By Application, 2017–2024 (USD Million)
Table 107 APAC: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 108 APAC: Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 109 APAC: Market, By End User, 2017–2024 (USD Million)
Table 110 China: Market, By Product, 2017–2024 (USD Million)
Table 111 China: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 112 China: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 113 China: Market, By Application, 2017–2024 (USD Million)
Table 114 China: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 115 China: Market, By End User, 2017–2024 (USD Million)
Table 116 Japan: Market, By Product, 2017–2024 (USD Million)
Table 117 Japan: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 118 Japan: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 119 Japan: Market, By Application, 2017–2024 (USD Million)
Table 120 Japan: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 121 Japan: Market, By End User, 2017–2024 (USD Million)
Table 122 India: Market, By Product, 2017–2024 (USD Million)
Table 123 India: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 124 India: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 125 India: Market, By Application, 2017–2024 (USD Million)
Table 126 India: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 127 India: Market, By End User, 2017–2024 (USD Million)
Table 128 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 129 RoAPAC: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 130 RoAPAC: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 131 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 132 RoAPAC: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 133 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 134 Latam: Market, By Country, 2017–2024 (USD Million)
Table 135 Latam: Market, By Product, 2017–2024 (USD Million)
Table 136 Latam: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 137 Latam: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 138 Latam: Market, By Application, 2017–2024 (USD Million)
Table 139 Latam: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 140 Latam: Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 141 Latam: Market, By End User, 2017–2024 (USD Million)
Table 142 Brazil: Market, By Product, 2017–2024 (USD Million)
Table 143 Brazil: Market, By Application, 2017–2024 (USD Million)
Table 144 Brazil: Market, By End User, 2017–2024 (USD Million)
Table 145 Mexico: Market, By Product, 2017–2024 (USD Million)
Table 146 Mexico: Market, By Application, 2017–2024 (USD Million)
Table 147 Mexico: Market, By End User, 2017–2024 (USD Million)
Table 148 RoLATAM: Market, By Product, 2017–2024 (USD Million)
Table 149 RoLATAM: Market, By Application, 2017–2024 (USD Million)
Table 150 RoLATAM: Market, By End User, 2017–2024 (USD Million)
Table 151 MEA: Market, By Product, 2017–2024 (USD Million)
Table 152 MEA: Synthesized Oligos Market, By Product, 2017–2024 (USD Million)
Table 153 MEA: Synthesized Oligos Market, By Type, 2017–2024 (USD Million)
Table 154 MEA: Market, By Application, 2017–2024 (USD Million)
Table 155 MEA: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 156 MEA: Market for Therapeutic Applications, By Type, 2017–2024 (USD Million)
Table 157 MEA: Market, By End User, 2017–2024 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Synthesized Oligos Dominates the Oligonucleotide Synthesis Market, By Product, 2019—2024 (USD Million)
Figure 5 Oligonucleotide-Based Drugs Segment to Record Highest Growth, 2019–2024 (USD Million)
Figure 6 Predesigned Oligos to Dominate the Oligonucleotide Synthesis Market
Figure 7 Therapeutic Applications Hold the Largest Market Share
Figure 8 Hospitals to Grow at the Highest CAGR in the End-User Market
Figure 9 North America Held Largest Share in 2018 and to Record Highest CAGR (2019–2024)
Figure 10 Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications are Driving Market Growth
Figure 11 Oligonucleotide-Based Drugs to Dominate the Market, 2019–2024 (USD Million)
Figure 12 Predesigned Oligos to Command the Largest Share of the Oligonucleotide Synthesis Market During the Forecast Period
Figure 13 PCR Held the Largest Share of the Asia Pacific Research Applications Market in 2019
Figure 14 DNA & Antisense Oligos to Register the Highest Growth Rate During the Forecast Period
Figure 15 Hospitals Segment to Witness Highest CAGR, 2019—2024 (USD Million)
Figure 16 the US to Record the Highest CAGR During the Forecast Period
Figure 17 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Synthesized Oligos to Record Highest CAGR During the Forecast Period
Figure 19 Therapeutic Applications to Offer Lucrative Growth Opportunities for Market Players During 2019—2024
Figure 20 Hospitals to Dominate the Oligonucleotide Synthesis Market During the Forecast Period
Figure 21 North America: Oligonucleotide Synthesis Market Snapshot
Figure 22 Europe: Oligonucleotide Synthesis Market Snapshot
Figure 23 APAC: Oligonucleotide Synthesis Market Snapshot
Figure 24 Latam: Oligonucleotide Synthesis Market Snapshot
Figure 25 MEA: Oligonucleotide Synthesis Market Snapshot
Figure 26 Key Developments in the Oligonucleotide Synthesis Market (Jan 2016-Jan 2019)
Figure 27 Market Evolution Framework
Figure 28 Global Oligonucleotide Synthesis Market Share Analysis (For Research and Diagnostics), By Key Player, 2017
Figure 29 MnM Dive-Vendor Comparison Matrix: Exosomes Market
Figure 30 Agilent Technologies: Company Snapshot
Figure 31 Eurofins Scientific Group: Company Snapshot
Figure 32 Kaneka: Company Snapshot
Figure 33 General Electric Company (GE): Company Snapshot
Figure 34 Genscript: Company Snapshot
Figure 35 Ajinomoto: Company Snapshot
Figure 36 Danaher Corporation: Company Snapshot
Figure 37 Merck KGaA: Company Snapshot
Figure 38 Nitto Denko Corporation: Company Snapshot
Figure 39 Thermo Fisher Scientific: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Adtbio
  • Agilent Technologies
  • Bio-Synthesis Inc.
  • Bioautomation (Acquired By LGC
  • Eurofins Genomics
  • Eurogentec
  • GE Healthcare
  • Genedesign (Part of Ajinomoto
  • Genscript
  • Integrated DNA Technologies (Acquired By Danaher Corporation)
  • LGC Biosearch Technologies
  • Merck KGaA
  • Nitto Denko Avecia
  • Thermo Fisher Scientific
  • TriLink Biotechnologies (Part of Maravai Lifesciences)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769493
Adroll
adroll